Effect of cefditoren pivoxil on carnitine metabolism in pediatric patients

R. Fujii, S. Chiba, K. Numazaki, T. Mori, I. Terashima, H. Meguro, A. Mori, Y. Toyonaga, K. Sunakawa, Y. Satoh, S. Iwata, H. Akita, N. Iwai

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Carnitine metabolism was studied in 16 pediatric patients with various infections under the treatment with cefditoren pivoxil (CDTR-PI) in granular form. Pivalic acid released from pivaloyloxymethyl ester of the drug was metabolized to pivaloylcarnitine. As results, an increase in urinary carnitine excretion (predominantly as pivaloylcarnitine) and, a decrease in free carnitine concentration and a high acyl/free carnitine ratio in serum (plasma) were observed during the treatment. When the dosing was terminated, pivaloylcarnitine in plasma and then in urine disappeared, and the concentration of free carnitine, acyl/free carnitine ratio returned to the normal range. No carnitine-related side effects were observed throughout the study.

Original languageEnglish
Pages (from-to)926-937
Number of pages12
JournalJapanese Journal of Antibiotics
Volume46
Issue number10
Publication statusPublished - 1993
Externally publishedYes

Fingerprint

cefditoren pivoxil
Carnitine
Pediatrics

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Fujii, R., Chiba, S., Numazaki, K., Mori, T., Terashima, I., Meguro, H., ... Iwai, N. (1993). Effect of cefditoren pivoxil on carnitine metabolism in pediatric patients. Japanese Journal of Antibiotics, 46(10), 926-937.

Effect of cefditoren pivoxil on carnitine metabolism in pediatric patients. / Fujii, R.; Chiba, S.; Numazaki, K.; Mori, T.; Terashima, I.; Meguro, H.; Mori, A.; Toyonaga, Y.; Sunakawa, K.; Satoh, Y.; Iwata, S.; Akita, H.; Iwai, N.

In: Japanese Journal of Antibiotics, Vol. 46, No. 10, 1993, p. 926-937.

Research output: Contribution to journalArticle

Fujii, R, Chiba, S, Numazaki, K, Mori, T, Terashima, I, Meguro, H, Mori, A, Toyonaga, Y, Sunakawa, K, Satoh, Y, Iwata, S, Akita, H & Iwai, N 1993, 'Effect of cefditoren pivoxil on carnitine metabolism in pediatric patients', Japanese Journal of Antibiotics, vol. 46, no. 10, pp. 926-937.
Fujii R, Chiba S, Numazaki K, Mori T, Terashima I, Meguro H et al. Effect of cefditoren pivoxil on carnitine metabolism in pediatric patients. Japanese Journal of Antibiotics. 1993;46(10):926-937.
Fujii, R. ; Chiba, S. ; Numazaki, K. ; Mori, T. ; Terashima, I. ; Meguro, H. ; Mori, A. ; Toyonaga, Y. ; Sunakawa, K. ; Satoh, Y. ; Iwata, S. ; Akita, H. ; Iwai, N. / Effect of cefditoren pivoxil on carnitine metabolism in pediatric patients. In: Japanese Journal of Antibiotics. 1993 ; Vol. 46, No. 10. pp. 926-937.
@article{9e2dbadaf13a4cb89a0513777990a4cd,
title = "Effect of cefditoren pivoxil on carnitine metabolism in pediatric patients",
abstract = "Carnitine metabolism was studied in 16 pediatric patients with various infections under the treatment with cefditoren pivoxil (CDTR-PI) in granular form. Pivalic acid released from pivaloyloxymethyl ester of the drug was metabolized to pivaloylcarnitine. As results, an increase in urinary carnitine excretion (predominantly as pivaloylcarnitine) and, a decrease in free carnitine concentration and a high acyl/free carnitine ratio in serum (plasma) were observed during the treatment. When the dosing was terminated, pivaloylcarnitine in plasma and then in urine disappeared, and the concentration of free carnitine, acyl/free carnitine ratio returned to the normal range. No carnitine-related side effects were observed throughout the study.",
author = "R. Fujii and S. Chiba and K. Numazaki and T. Mori and I. Terashima and H. Meguro and A. Mori and Y. Toyonaga and K. Sunakawa and Y. Satoh and S. Iwata and H. Akita and N. Iwai",
year = "1993",
language = "English",
volume = "46",
pages = "926--937",
journal = "The Journal of antibiotics. Ser. B",
issn = "0368-2781",
publisher = "Japan Antibiotics Research Association",
number = "10",

}

TY - JOUR

T1 - Effect of cefditoren pivoxil on carnitine metabolism in pediatric patients

AU - Fujii, R.

AU - Chiba, S.

AU - Numazaki, K.

AU - Mori, T.

AU - Terashima, I.

AU - Meguro, H.

AU - Mori, A.

AU - Toyonaga, Y.

AU - Sunakawa, K.

AU - Satoh, Y.

AU - Iwata, S.

AU - Akita, H.

AU - Iwai, N.

PY - 1993

Y1 - 1993

N2 - Carnitine metabolism was studied in 16 pediatric patients with various infections under the treatment with cefditoren pivoxil (CDTR-PI) in granular form. Pivalic acid released from pivaloyloxymethyl ester of the drug was metabolized to pivaloylcarnitine. As results, an increase in urinary carnitine excretion (predominantly as pivaloylcarnitine) and, a decrease in free carnitine concentration and a high acyl/free carnitine ratio in serum (plasma) were observed during the treatment. When the dosing was terminated, pivaloylcarnitine in plasma and then in urine disappeared, and the concentration of free carnitine, acyl/free carnitine ratio returned to the normal range. No carnitine-related side effects were observed throughout the study.

AB - Carnitine metabolism was studied in 16 pediatric patients with various infections under the treatment with cefditoren pivoxil (CDTR-PI) in granular form. Pivalic acid released from pivaloyloxymethyl ester of the drug was metabolized to pivaloylcarnitine. As results, an increase in urinary carnitine excretion (predominantly as pivaloylcarnitine) and, a decrease in free carnitine concentration and a high acyl/free carnitine ratio in serum (plasma) were observed during the treatment. When the dosing was terminated, pivaloylcarnitine in plasma and then in urine disappeared, and the concentration of free carnitine, acyl/free carnitine ratio returned to the normal range. No carnitine-related side effects were observed throughout the study.

UR - http://www.scopus.com/inward/record.url?scp=0027426919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027426919&partnerID=8YFLogxK

M3 - Article

C2 - 8254895

AN - SCOPUS:0027426919

VL - 46

SP - 926

EP - 937

JO - The Journal of antibiotics. Ser. B

JF - The Journal of antibiotics. Ser. B

SN - 0368-2781

IS - 10

ER -